STOCK MARKET BSE NSE

Biological E Bags Order for Supply of Pentavalent Vaccine

Published: 22nd March 2016 06:20 AM  |   Last Updated: 22nd March 2016 06:20 AM   |  A+A-

HYDERABAD:  Vaccine company Biological E Limited (BE) has bagged an order for supplying ComBE Five, a 5-in-1 Liquid Pentavalent Vaccine (LPV) to the Union ministry of health & family welfare.

The Hyderabad-based company will supply the vaccine for over a period of two years. It will be inducted into the Union government’s Universal Immunisation Programme (UIP) and give a boost to Mission Indradhanush, an initiative to empower full immunisation coverage to at least 90 pc children of the country.

“The over Rs 895 crore order placed on BE to be supplier of ‘ComBE Five’ over a period of two years is a testimony to the BE’s commitment to preserving health and well-being while adhering to high standards of quality and safety. It is a momentous occasion for our company and we are proud to be at the forefront of the UIP of India,” Mahima Datla, managing director of the company, said in a release here on Monday.

“It is also a historical moment because ‘Hib’ vaccine is being rolled out all over India. BE has supported the UIP right from its inception as a major vaccine manufacturer. For BE, India is the most significant market and this contract will contribute to BE’s growth. We are very proud to contribute to the Make-in-India initiative by becoming one of the world’s largest vaccine manufacturers of LPV,” she added.

As part of its expansion in the state, BE is investing more than Rs 500 crore in building new facilities over a period of three years to augment its production capacity for vaccines as well as complex generics. This is expected to generate additional employment for over 600 people.

BE’s ComBE Five has received World Health Organization’s pre-qualification approval. The vaccine consists of diphtheria, tetanus, pertussis, Hib (Haemophilus Influenza Type b) and Hepatitis B.

Founded in 1953, BE is the first private sector biological products company in India and the first pharmaceutical company in South India. Originally incorporated as Biological Products Private Limited, it is a globally recognised vaccine manufacturer and has supplied over two billion doses of vaccine till date all over the world.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp